We are live on ! Find out more
CO

Global Cord Blood Corporation
CO

Delisted

CO was delisted on the 23rd of September, 2022.

Back to rankings

2 hedge funds and large institutions have $71.4K invested in Global Cord Blood Corporation in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital invested

Capital invested by funds: $64.5K → $71.4K (+$6.88K)

0% more funds holding

Funds holding: 2 → 2 (0)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$71.1K – – –
OA
2
Operose Advisors
Wisconsin
$270 – – –

CO Hedge Fund Activity: Q1 2024 in Review

2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2024, worth a combined $71.4K — up 11% from $64.5K a quarter earlier.

Fund positioning in CO was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $71.4K of Global Cord Blood Corporation stock for Q1 2024, up 11% quarter-over-quarter.
  • 0 funds opened new Global Cord Blood Corporation positions in Q1 2024 and 0 closed out.

Based on aggregated 13F filings for Q1 2024.